Optometrists in Tiverton, RI Accepting Medicare

2 Optometrists found. Showing 1 - 2

Joseph A Boivin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1820 Main Rd, Tiverton, RI 02878 Phone: 401-624-6672    Fax: 401-624-4769

Joseph A Boivin O.d., Ltd Optometrist Medicare: Medicare Enrolled Practice Location: 1820 Main Rd, Tiverton, RI 02878 Phone: 401-624-6672    Fax: 401-624-4769

News Archive

SAFC Pharma augments assay development capabilities

SAFC Pharma, a business segment of SAFC, a member of the Sigma-Aldrich group, today announced that it has commenced operations at its 7,000 sq. ft. state-of-the-art laboratory complex in Carlsbad, CA.

Combination of inhibitor and antioxidants may help prevent diabetes complications

In diabetes patients, high blood glucose levels can end up killing certain cells in the eyes and kidneys, which is why diabetes is the leading cause of adult blindness and of kidney failure. Years ago, scientists identified one main route for this destruction—high glucose produces oxidative stress through the NF-kB molecular pathway—but success has been elusive for drugs targeting that pathway.

First Edition: August 10, 2012

Reporting for Kaiser Health News, in collaboration with The Washington Post, Susan Jaffe writes: "Concerned that a growing number of seniors have been unexpectedly forced to pay thousands of dollars for nursing home care after a stay in a hospital, Medicare has launched a pilot project to test whether relaxing its hospital payment rules could help beneficiaries".

Diagnosis and treatment of nonalcoholic fatty liver disease

Gastroenterology, the official journal of the American Gastroenterological Association (AGA), has released a special issue providing clinicians and researchers an up-to-date resource on the risk factors, natural history, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD).

IRIDEX Cyclo G6 Laser System receives FDA clearance for treatment of glaucoma

IRIDEX Corporation today announced that it has received clearance from the U.S. Food and Drug Administration to market its first laser system designed solely for use in treating glaucoma and its symptoms. Specifically, the Company was granted 510(k) clearance for the IRIDEX Cyclo G6 Laser System (with delivery devices).

Read more Medical News

› Verified 2 days ago